Flyer: Monkeypox oligos – Primers & Probes
Posted: 17 November 2022 | Merck | No comments yet
Monkeypox oligos – Primers & Probes for Research & Commercial use.
The outbreak of Monkeypox has increased the demand for primers and probes for qPCR-based detection.
We are committed to providing researchers and assay developers with the products, reagents and technical expertise to address the Monkeypox outbreak.
Rely on our 35+ years of experience and global supply chain to provide you with expertly manufactured and reliably delivered oligos.
Related content from this organisation
- Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
- First-in-class biologic approved for rare lung disease
- Mycoplasma testing market expected to value nearly $2 million by 2031
- Pharmaceutical suspension market to witness accelerated growth
- Immunotherapy drug achieves trial-first in fifty years
